105751-19-7 Usage
Description
FMOC-D-PIPECOLIC ACID, also known as N-(9-Fluorenylmethoxycarbonyl)-D-pipecolic acid, is a synthetic compound commonly used in the field of organic chemistry and pharmaceutical research. It is a derivative of pipecolic acid, featuring a 9-fluorenylmethoxycarbonyl (Fmoc) protecting group, which is crucial for its applications in peptide synthesis and other chemical reactions. The Fmoc group provides selectivity and stability, making FMOC-D-PIPECOLIC ACID a valuable reagent in various chemical processes.
Uses
Used in Pharmaceutical Research:
FMOC-D-PIPECOLIC ACID is used as a reactant for the racemic solid-phase preparation of human protease-activated receptor 2 (PAR2) agonists and antagonists. These compounds play a significant role in various physiological processes, including inflammation, pain, and blood clotting. The development of PAR2 agonists and antagonists can lead to novel therapeutic strategies for treating conditions such as asthma, chronic obstructive pulmonary disease (COPD), and inflammatory bowel disease (IBD).
Used in Analytical Chemistry:
FMOC-D-PIPECOLIC ACID serves as an analyte for urea-linked cinchona-calexarene hybrid type receptors in the chromatographic enantiomer separation of carbamate-protected amino acids. This application is essential for the purification and analysis of chiral compounds, which are crucial in the pharmaceutical industry due to their different biological activities and potential for improved drug efficacy and reduced side effects.
Used in Combinatorial Chemistry:
FMOC-D-PIPECOLIC ACID is employed as a combinatorial reactant for the assembly of alkylglycine library arrays using the SPOT (Synthetic Peptide On Tape) technique on cellulose membranes. This method allows for the identification of micromolar ligands for monoclonal antibodies, which can be used in the development of new drugs and therapeutic agents. The SPOT technique is a powerful tool for high-throughput screening and the discovery of novel bioactive compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 105751-19-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,7,5 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 105751-19:
(8*1)+(7*0)+(6*5)+(5*7)+(4*5)+(3*1)+(2*1)+(1*9)=107
107 % 10 = 7
So 105751-19-7 is a valid CAS Registry Number.
InChI:InChI=1/C21H21NO4/c23-20(24)19-11-5-6-12-22(19)21(25)26-13-18-16-9-3-1-7-14(16)15-8-2-4-10-17(15)18/h1-4,7-10,18-19H,5-6,11-13H2,(H,23,24)/t19-/m1/s1
105751-19-7Relevant articles and documents
Synthesis of Shld Derivatives, Their Binding to the Destabilizing Domain, and Influence on Protein Accumulation in Transgenic Plants
J?rgensen, Frederik Pr?stholm,Madsen, Daniel,Meldal, Morten,Olsen, Jacob Valdbj?rn,Petersen, Morten,Granh?j, Jeppe,Bols, Mikael
, p. 5191 - 5216 (2019/05/28)
A series of 35 analogues of Shld with modifications in the A-residue and the C-residues were prepared and investigated for binding to FKBP and GFP accumulation in transgenic plants. The modifications investigated explored variations that were supposedly i
Heterocyclic core analogs of a direct thrombin inhibitor
Blizzard, Timothy A.,Singh, Sanjay,Patil, Basanagoud,Chidurala, Naresh,Komanduri, Venukrishnan,Debnath, Samarpita,Belyakov, Sergei,Crespo, Alejandro,Struck, Alice,Kurtz, Marc,Wiltsie, Judyann,Shen, Xun,Sonatore, Lisa,Arocho, Marta,Lewis, Dale,Ogletree, Martin,Biftu, Tesfaye
, p. 1111 - 1115 (2014/03/21)
Thrombin is a serine protease that plays a key role in blood clotting. Pyrrolidine 1 is a potent thrombin inhibitor discovered at Merck several years ago. Seven analogs (2-8) of 1 in which the pyrrolidine core was replaced with various heterocycles were p
PIPECOLATE-DIKETOAMIDES FOR TREATMENT OF PSYCHIATRIC DISORDERS
-
Page/Page column 41, (2013/07/05)
The present invention relates to compounds having a pipecolate diketoamide scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said pipecolate diketoamide compounds can be used for prophylaxis and/or treatment of psychiatric disorders and neurodegenerative diseases, disorders and conditions.